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Abstract: Paracetamol which is widely used as anti-inflammatory drug and pain killer is known to cause liver 
injury. Vitamins A and E are among the antioxidants vitamins that have attracted the attention of biochemical and 
toxicological researchers in the recent times as vitamin A is reported to enhance a marked reduction in CCl-induced 
hepatic damage, this study was aiming to investigate the hepatoprotective effect of vitamin A (retinol) against 
paracetamol-induced toxicity in Wister rats. Five groups of rats  were used in a seven days experiment; The control 
group received no treatment, the negative control grouphas received single dose of PCM (1000mg/kg, orally) on  
day7and groups  3,  4,  and  5    received  oral  doses  of  vitamin A of 100IU/kg,  500IU/kg,  and 1000  IU/kg,  
respectively  for  7  days and in the last day (7thday) they received a  single  dose  of PCM of 1000mg/kg/orally.  
Animals  were  sacrificed  in  day  8  and  blood  samples  were collected  and used for  analysis  of ALT, AST, 
albumin, total protein, cholesterol, triacylglycerides and total bilirubin. The group of rats used as negative control 
showed significant elevation in serum ALT, AST, cholesterol and bilirubin levels when compared with the control 
group. A dose of 1000 IU/kg vitamin A has showed protective effects against PCM induced hepatotoxicity. 
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1. INTRODUCTION 
Liver is the principal organ for maintaining the 
body’s internal environment. It plays major functions 
in the metabolism of carbohydrate, protein, fats and 
processing and excretion of xenobiotics (1). 
Overdoses of many medicinal drugs can cause liver 
injury (2) which lead to elevated levels of 
aminotransferases and yellowing of the skin, eyes and 
mucous membranes due to high level of bilirubin(3). 
Drug-induced liver injury is due to a drug over dose 
or its toxic metabolite which affect the immune 
response or alter the biochemistry of the hepatic 
tissue(4). Paracetamol (PCM) is most popular anti-
inflammatory drug used as a pain killer(5). When 
PCM is taken in overdose it leads to liver toxicity (6) 
and renal tubular necrosis, which can be lethal in 
human and animal. Alteration in homeostatic status 
leads to a shift in the dynamic equilibrium of 
metabolism toward the ROS generation thereby 
oxidative stress leading to organ dysfunction(7). 
Several studies about protection against 
hepatotoxicity have been performed (8) and up to 
date there are no completely effective drugs that 
stimulate hepatic function, that offer complete 
protection of the organ(9). Some vitamins are known 
to play an important role in ameliorating the toxicity 
effects of reactive species generated by chemical 
agents in the biological systems. It has been 
documented that Vitamin C, and Vitamin E minimize 
the  hepatotoxicity (10). Vitamins A and E are among 
the antioxidants vitamins that have attracted the 
attention of biochemical and toxicological researchers 
in the recent times. Vitamin A is reported to enhance 
a marked reduction in CCl-induced hepatic damage 
(11) 
This study was aiming to investigate the 
hepatoprotective effect of vitamin A (retinol) against 
paracetamol-induced toxicity in Wister rats by 
studying the liver function through the AST, ALT, 
bilirubin, Total protein, Albumin, Cholesterol and 
Triglyceride level and through liver histology 
examination. 
2. MATERIALS AND METHODS 
Drugs:  
Paracetamol (PCM): Was obtained from local 
market, Khartoum, Sudan, Amipharma Laboratories 
Ltd. It was dissolved in distilled water and 
administered as a single oral dose of 1000 mg/kg 
body weight. According to literature, this dose is 10 
times the therapeutic dose. 
Vitamin "A": Was obtained from local market, 
Kahira Pharm & Chem.ind.co. It was dissolved in 
olive oil and given daily as an oral dose of 
1000mg/kg. 
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Animals: 
Twenty six  apparently  healthy,  albino  Wister  male  
rats with  an  average  weight  of  100  gm  were  
selected  for  the study.  The animals were housed in 
the animal house of Medicinal and Aromatic Plant 
and Traditional Medicine research Institute under 
standard laboratory conditions. The rats were given 
standard rat pellets and water. They were  optimized  
to  laboratory  conditions  for  one  week before  
starting  the  experiment.  The study was carried out 
in the period from November 2016 through February 
2017.  
Study Design 
Rats were randomly divided into five groups: group1; 
(control) that comprise 6 rats that sacrificed in day 8 
without receiving any kind of treatment, group 2; 
PCM-treated group, where each rat of the 6 rats in 
this group, was given tap water for 7 days orally and  
on  the  7th day rats received  a  single  oral  dose of  
1000  mg/kg  body  weight of PCM,  then sacrificed 
at day 8. In group 3, 4 and 5, each animal of the 
group was treated with a single daily 100, 500 and 
1000 IU/kg body weight vitamin A orally, 
respectively, for one week and on  day 7  received  a  
single  oral  dose  of  PCM  1000mg/kg body weight. 
At  the  end  of  the  treatment (day 8),  animals  were  
sacrificed and  the  blood  was  drawn  out  from each  
animal and collected  in  sterilized  plastic plain 
tubes, and left to stand for 30 minutes at 25°C,  then  
centrifuged at  3000 rpm  for  15  minutes and then, 
the   sera    were  collected and stored at 4°C  for  
measurement  of  serum  ALT,  AST, total protein, 
albumin, triglyceride, cholesterol and total bilirubin  
using  a  ready-made  kit  for  this  purpose from 
Biosystems, S.A. Costa. Brava 30, 08030 Barcelona, 
Spain. After  collecting blood samples, the abdominal  
cavity  was  immediately  opened  and  the  liver was 
dissected out of each animal, washed  with  distilled 
water and fixed in10% formaldehyde at room 
temperature, then passed through dehydration,  
cleaning,  embedding  with  paraffin  wax  to form  
paraffin  blocks  which  sectioned  to  5  µm  
thickness using  microtome. These sections where 
stained with Harris hematoxylin and Eosin (H&E) 
stains for microscopic histological examination. 
3. STATISTICAL ANALYSIS 
Statistical  analysis  was  performed  using  SPSS  
(Statistical Package  for  Social  Sciences,  version  
22,  and  Microsoft Excel  software.  Results were 
expressed as mean ± standard deviation or standard 
error. Independent -Samples T-test was used to 
compare between groups.  P value of ≤ 0.05 is 
considered significant. 
4. RESULTS 
1. Biochemicals 
Serum levels of AST and ALT in negative control 
group was found to be significantly higher than in 
that of the control group (P=0.038 and 0.003, 
respectively. The levels of serum AST and ALT in 
100IU/kg vitamin A-treated group were not 
significantly different when compared to the enzyme 
levels in PCM-treated group where p values were 
0.355 and 0.399 respectively. The levels of the 
transaminases in 500IU/kg vitamin A-treated group 
were clearly declined; particularly the ALT which 
shows significant low level compared to the negative 
control, P values for AST and ALT were 0.08 and 
0.015, respectively. In the group  treated with 1000 
IU/Kg of vitamin, the levels of the enzymes AST and 
ALT were found to be significantly low when 
compared to the control group where P values were 
0.034, 0.006, respectively figure (1). Serum total 
protein and serum albumin in PCM-treated group 
were less than that of the control group but the 
decrease was not significant (P=0.419, 0.733 
respectively). Although statistically insignificant, but, 
in all treated groups there were observable vitamin 
dose-dependent increase in albumin (P=0.584, 0.654, 
0.281) for a dose of 100, 500, and 1000 IU/Kg 
vitamin, respectively). The comparison between the 
values of the total protein in the vitamin-treated 
groups and the negative control group revealed that, 
the 100, 500 and 1000 IU/Kg of vitamin has 
observable positive effect but again statistically 
insignificant; P values were 0.232, 0.144, 0.952 for 
vitamin doses of 100, 500 and 1000 IU/Kg vitamin 
respectively (figure 2). Although insignificant, 
cholesterol concentration is higher in PCM-treated 
group than in both control group (P = 0.595) and 
vitamin A-treated groups, (P = 0.301, 0.563, 0.347) 
for 100, 500 and 1000 IU of vitamin, respectively. 
Serum triglycerides (TGs) concentration was found to 
be group significantly higher in control group when 
compared to that of the PCM-treated group (P=0.03). 
At low doses of vitamin (100 IU and 500 IU) there 
was no significant difference in the concentration of 
TGs compared to the PCM-treated group (P=0.484, 
0.859 respectively), whereas at dose 1000 IU of 
vitamin, there was significant increase in TGs 
compared to the PCM-treated group (P=0.023) figure 
(3).The PCM treatment increases the serum bilirubin 
concentration significantly when compared to the 
control group (P = 0.044) whereas, the low doses of 
vitamin A (100 IU/kg and 500 IU/kg) did not show 
significant effect in decreasing bilirubin 
concentration induced by PCM (P = 0.261, 0.08 
respectively). However, 1000 IU/kg of vitamin A has 
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decreased the concentration of serum bilirubin 
induced by PCM significantly (P=0.008) figure (4). 
 
 
Figure1:Effect of different doses of vitamin A on 
serum ALT, AST levels of PCM-treated group 
compared to PCM-treated group (neg. control). *; 
indicates the significant difference compared to the 
negative control. 
 
Figure2: Effect of different doses of vitamin A on 
serum total protein and albumin levels of PCM-
treated compared to PCM-treated (neg. control). 
 
Figure3:Effect of (different doses of vitamin A on 
serum cholesterol and Triglyceride levels compared 
to PCM-treated group.*;indicates the significant 
difference compared to the negative control. 
 
 
Figure4:Effect of (different doses of vitamin 
A+PCM) on serum bilirubin levels compared to 
PCM-induced group (neg. control).*;indicates the 
significant difference compared to the negative 
control. 
2. Liver histology 
As shown in the photomicrograph of the liver section 
from normal control group stained by H&E (figure 
5), the hepatocytes showed normal tissue architecture 
and cellular outline, the nuclei are normal in shape 
and size seen around the central vein region (CV) 
(Figure 5A). While the histopathological examination 
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of the liver tissue of rats treated with single dose of 
PCM of 1000mg/kg body weight (figure 5B) showed 
marked congestion of central vein with hemorrhage, 
degenerative hepatocytes (destruction of cell wall and 
absence of nuclei), various degree of cellular necrosis 
evident by the present of different form of nucleus 
changes which include: karyopyknosis, karyogensis 
and karyorrhexis. Liver sections from rats pretreated 
with vitamin A 1000IU/kg for one week followed by 
1000 mg PCM/kg body weight showed a normal 
view of hepatic tissue with mild degenerative and 
necrotic changes, some degree of fatty change and 
some nuclei are variable in size and shape (Figure 
5C). 
 
 
 
Figure5: A; Normal control group, B; PCM-treated 
group. C; (vitamin A, 1000 IU/kg + PCM) group. 
5. DISCUSSION: 
The liver is involved in the biochemical processes 
such as growth, supplying energy as well as it 
participate in the metabolism of carbohydrates, 
proteins and fats, bile acids, and in the storage of 
vitamins(9). Drug-induced hepatotoxicity is a 
common cause of liver injury(4). Paracetamol (PCM) 
hepatotoxicity is due to the reaction of its metabolite 
which causes oxidative stress and glutathione (GSH) 
depletion (12). PCM is also shown to directly inhibit 
cellular proliferation resulting in lipid peroxidation, 
depletion of ATP, and alteration of homeostasis. All 
of these changes are considered potentially fatal to 
the cell (13). The sensitivity of liver to the toxic 
agents is usually seen in the levels of different 
enzyme activities such as AST, ALT, and in the 
levels of total bilirubin and total protein (14). In this 
study it was observed that giving vitamin A orally at 
doses of 100, 500, 1000 IU/kg, on daily basis resulted 
in a dose-dependent decreases of serum 
aminotransferases compared to the paracetamol-
induced liver injury group. This indicated that 
vitamin A has positive effect in liver cells 
regeneration. The actual mechanism of decreased 
levels of the enzymes concentration were not studied 
but, vitamin A may cause regeneration of damaged 
hepatocytes through one of the several signaling 
pathways known to stimulate regeneration in the liver 
including cytokines, growth factors, hormones, and 
nuclear receptors, or it may act as scavenger of free 
radicals that cause liver injury like the action that 
exerted by tocopherols (15).  
It was also observed that PCM has lowering effect of 
both the total serum protein and albumin. As the liver 
synthesizes many species of plasma proteins 
including the Albumin, α globulins, β-globulins, 
fibrinogens and others, the damaged cells were 
incapable of synthesizing normal amount of proteins. 
Although the difference was not significant when 
compared with the control group but the measured 
concentrations were observed to be less in the PCM-
treated group.In all vitamin A-treated groups, the 
liver has retained its function and the levels of both 
albumin and total proteins were increased to the 
levels of controls. This is clearly indicates that 
vitamin A pretreatment can prevents the liver from 
being injured and improve the liver function. As the 
liver play vital role in the metabolism, conjugation of 
bilirubin to glucouoronic acid and its regulation and 
secretion into the bile, the PCM treatment in this 
study was shown to negatively affect this function. 
As shown in the results section, total bilirubin 
concentration was significantly increased in PCM 
group compared to the normal healthy control group. 
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The damage of the rat hepatocytes as seen in the 
histopathology slides may be the direct cause of this 
dysfunction of the hepatocytes, thus, the failure of 
hepatocytes to conjugate the bilirubin and to excrete 
it in the bile. On the other hand, the significant 
decline of serum bilirubin in vitamin A treated groups 
confirms the hepatoprotective activity of vitamin A 
which agreed with finding reported  by Effiong et al 
that rats exposed to gasoline vapors and treated with 
retinol has recovered from the hepatotoxicity and 
retain normal serum bilirubin (17). Both the 
triacylglycerols (TGs) and cholesterol were affected 
by both PCM and by vitamin A treatment, where an 
oral administration of overdose of PCM significantly 
decreased serum triglyceride (P=0.03).  This decrease 
in TGs could be due to hepatotoxicity that has been 
associated with excessive intake of PCM (18). In all 
vitamin A-treated groups there were increase in 
triglyceride concentration and particularly in the 
group treated with 1000IU/kg (P = 0.023). This is 
may be due to increased lipid soluble vitamin A 
uptake by liver. Although insignificant, there was an 
increase in the cholesterol levels of the PCM treated 
group when compared with the normal group. The 
liver is central to the regulation of cholesterol levels 
in the body, not only does it synthesize cholesterol 
for export to other cells but it also removes 
cholesterol from the body by converting it to bile 
salts and excreting it into the bile, so, this function 
may altered or the impaired catabolism of 
chylomicron remnant gives rise to increase in serum 
cholesterol. The attenuation in serum total cholesterol 
concentration observed in the vitamin A treated rats 
may be due to increase in the serum HDL-cholesterol 
concentration and TG, because vitamin A supplement 
was provided with fat, which aids the esterification 
and packaging of retinol into chylomicron. HDL-
cholesterol mobilizes cholesterol into the cells 
(19).The biochemical results were also proved by 
histological manifestations. The changes mostly 
comprise hepatocellular necrosis, fatty accumulation 
and other histological observations added more 
verification to the hepatoprotective influence of 
vitamin A particularly at dose 1000IU/kg. 
6. CONCLUSION 
The present investigations indicated that vitamin A at 
all doses exhibits significant barrier against 
paracetamol-induced toxicity. A dose of 1000IU/kg 
of vitamin A is more effective than doses of 100 and 
500IU/kg of the vitamin. Further investigation is 
necessary to determine the effect of vitamin A at the 
molecular level and the mechanism of liver 
protection against paracetamol toxicity. 
7. ACKNOWLEDGEMENT 
The authors wish to acknowledge with deep 
appreciation the biochemistry lab member in Sudan 
Atomic Energy Commission for their technical 
support. 
 
REFERENCES: 
1.  Singh A, K Bhat T, Sharma O. clinical-
biochemistry-of-hepatotoxicity-2161-0495. S4-
001. 2015.  
2.  Papay JI, Clines D, Rafi R, Yuen N, Britt SD, 
Walsh JS, et al. Drug-induced liver injury 
following positive drug rechallenge. Regul 
Toxicol Pharmacol. 2009 Jun 1;54(1):84–90.  
3.  Chang CY, Schiano TD. Review article: drug 
hepatotoxicity. Aliment Pharmacol Ther. 2007 
May 1;25(10):1135–51.  
4.  Kaplowitz N. Drug-Induced Liver Injury. Clin 
Infect Dis. 2004 Mar 1;38 (Supplement_2): S44–
8.  
5.  Feng D, Wang Y, Wang H, Weng H, Kong X, 
Martin-Murphy BV, et al. Acute and Chronic 
Effects of IL-22 on Acetaminophen-Induced 
Liver Injury. J Immunol Baltim Md 1950. 2014 
Sep 1;193(5): 2512–8.  
6.  Jiang Y, Wang Y, Tan H, Yu T, Fan X, Chen P, 
et al. Schisandrol B protects against 
acetaminophen-induced acute hepatotoxicity in 
mice via activation of the NRF2/ARE signaling 
pathway. Acta Pharmacol Sin. 2016 
Mar;37(3):382–9.  
7.  Upadhyay G, Singh AK, Kumar A, Prakash O, 
Singh MP. Resveratrol modulates pyrogallol-
induced changes in hepatic toxicity markers, 
xenobiotic metabolizing enzymes and oxidative 
stress. Eur J Pharmacol. 2008 Oct; 596(1–
3):146–52.  
8.  Jaeschke H, Williams CD, McGill MR, Xie Y, 
Ramachandran A. Models of drug-induced liver 
injury for evaluation of phytotherapeutics and 
other natural products. Food Chem Toxicol Int J 
Publ Br Ind Biol Res Assoc. 2013 May; 55:279–
89.  
9.  Madrigal-Santillán E, Madrigal-Bujaidar E, 
Álvarez-González I, Sumaya-Martínez MT, 
Gutiérrez-Salinas J, Bautista M, et al. Review of 
natural products with hepatoprotective effects. 
World J Gastroenterol WJG. 2014 Oct 
28;20(40):14787–804.  
10.  Ebuehi O a. T, Ogedegbe RA, Ebuehi OM. Oral 
administration of vitamin C and vitamin E 
ameliorates lead-induced hepatotoxicity and 
International Journal of Academic and Applied Research (IJAAR) 
ISSN: 2000-005X   
Vol. 3 Issue 3, March  – 2019, Pages: 19-24 
 
 
http://www.ijeais.org/ijaar 
24 
 
oxidative stress in the rat brain. Niger Q J Hosp 
Med. 2012 Jun; 22(2):85–90.  
11.  Hooser SB, Rosengren RJ, Hill DA, Mobley SA, 
Sipes IG. Vitamin A modulation of xenobiotic-
induced hepatotoxicity in rodents. Environ 
Health Perspect. 1994 Nov;102 Suppl 9:39–43.  
12.  Lee WM. Acetaminophen and the U.S. Acute 
Liver Failure Study Group: lowering the risks of 
hepatic failure. Hepatol Baltim Md. 2004 
Jul;40(1):6–9.  
13.  Hinson JA, Roberts DW, James LP. Mechanisms 
of Acetaminophen-Induced Liver Necrosis. 
Handb Exp Pharmacol. 2010;(196):369–405.  
14.  Vaishwanar I, Kowale CN, Jiddewar GG. Effect 
of two Ayurvedic drugs Shilajeet & Eclinol on 
changes in liver & serum lipids produced by 
carbon tetrachloride. Indian J Exp Biol. 1976 
Jan;14(1):57–8.  
15.  Kartha VN, Krishnamurthy S. Antioxidant 
function of vitamin A. Int J Vitam Nutr Res Int 
Z Vitam- Ernahrungsforschung J Int Vitaminol 
Nutr. 1977;47(4):394–401.  
16.  Thapa BR, Walia A. Liver function tests and 
their interpretation. Indian J Pediatr. 2007 
Jul;74(7):663–71.  
17.  Uboh FE, Ebong PE, Umoh IB. Comparative 
Hepatoprotective Effect of Vitamins A and E 
Against Gasoline Vapor Toxicity in Male and 
Female Rats. Gastroenterol Res. 2009 
Oct;2(5):295–302.  
18.  Kobashigawa JA, Kasiske BL. Hyperlipidemia 
in solid organ transplantation. Transplantation. 
1997 Feb 15;63(3):331–8.  
19.  Batista M da CR, Franceschini S do CC. Impact 
of nutritional counseling in reducing serum 
cholesterol in public health service patients. Arq 
Bras Cardiol. 2003 Feb;80(2):16 
 
